Moderna Inc (MRNA)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -4,714,000 | -3,466,000 | 1,207,000 | 4,784,000 | 8,362,000 | 11,765,000 | 14,055,000 | 14,638,000 | 12,202,000 | 7,061,000 | 3,495,000 | 598,000 | -747,000 | -597,269 | -487,484 | -505,424 | -514,000 | -532,123 |
| Total assets | US$ in thousands | 18,426,000 | 19,450,000 | 21,884,000 | 24,125,000 | 25,858,000 | 26,056,000 | 26,043,000 | 27,609,000 | 24,669,000 | 20,923,000 | 16,153,000 | 12,694,000 | 7,337,000 | 4,650,870 | 3,486,010 | 2,067,540 | 1,589,420 | 1,590,900 |
| ROA | -25.58% | -17.82% | 5.52% | 19.83% | 32.34% | 45.15% | 53.97% | 53.02% | 49.46% | 33.75% | 21.64% | 4.71% | -10.18% | -12.84% | -13.98% | -24.45% | -32.34% | -33.45% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $-4,714,000K ÷ $18,426,000K
= -25.58%
To analyze Moderna Inc's return on assets (ROA) based on the provided data, we observe a declining trend in ROA over the last eight consecutive quarters. In Q1 2022, the ROA was at its peak at 53.02%, indicating that the company was generating a substantial return on its assets. However, the ROA began to decline thereafter, with negative ROA figures recorded in the most recent two quarters.
The significant drop in ROA from 53.02% in Q1 2022 to -25.58% in Q4 2023 raises concerns regarding the company's ability to efficiently utilize its assets to generate profits. This decline could be attributed to various factors such as increased operating expenses, lower revenue generation, or ineffective asset management.
The negative ROA values in the last two quarters raise additional red flags as it indicates that the company is experiencing losses rather than generating profits from its assets. Investors and stakeholders may view this trend unfavorably as it suggests a deterioration in the company's overall financial performance and efficiency in utilizing its assets.
In conclusion, Moderna Inc's declining ROA trend, culminating in negative values in the most recent quarters, indicates challenges in optimizing asset utilization and profitability. Further analysis of the company's financial and operational performance is advisable to understand the underlying reasons for the decreasing ROA and to assess the company's future financial prospects.
Peer comparison
Dec 31, 2023